Ozempic carries a list price of $1,027.51 per month for any dose, but what you actually pay depends entirely on whether you have insurance, what that insurance covers, and whether you’re using it for diabetes or weight loss. Most people using Ozempic specifically for weight loss end up paying out of pocket, and the realistic range is $199 to $499 per month through manufacturer pricing programs, or closer to $1,400 at full retail.
The List Price vs. What You Actually Pay
Novo Nordisk sets the wholesale acquisition cost at $1,027.51 for a one-month pen, regardless of whether it’s the 0.5 mg, 1 mg, or 2 mg dose. That’s the price before any discounts, rebates, or negotiated rates. At the pharmacy counter without any discount, the average retail price runs around $1,388 to $1,475 depending on the dose and location.
Almost nobody pays that full amount. Discount programs like GoodRx bring the price down significantly. Through the manufacturer’s own pricing for self-pay patients, the cost structure works like this:
- First two months (0.25 mg or 0.5 mg starter doses): $199 per month through an introductory offer available through June 30, 2026
- Ongoing at 0.25 mg, 0.5 mg, or 1 mg: $349 per month
- Ongoing at 2 mg: $499 per month
These self-pay prices bypass insurance entirely. They don’t count toward your deductible or out-of-pocket maximum, so there’s no indirect benefit to running them through your plan.
Why Insurance Rarely Covers It for Weight Loss
Ozempic is FDA-approved for type 2 diabetes, not weight loss. When doctors prescribe it for weight loss, that’s considered off-label use. Insurers typically won’t cover off-label Ozempic unless you also have a type 2 diabetes diagnosis. Even then, some employers specifically exclude GLP-1 drugs from their health plans.
If your insurer does cover Ozempic for diabetes, the manufacturer’s savings card can bring your copay down to as little as $25 per month for up to 48 months, with a maximum savings of $100 per fill. That card is only for people with commercial insurance that already covers the drug. Government insurance beneficiaries (Medicare, Medicaid, Tricare) are excluded.
Some insurers will cover weight loss medications if you have an obesity-related condition like high blood pressure or high cholesterol, but this varies widely and often requires prior authorization. The practical reality for most people seeking Ozempic purely for weight loss: plan on paying out of pocket.
Medicare Is Changing, but Slowly
Medicare has historically been prohibited from covering weight loss medications. That’s beginning to shift. CMS is launching a temporary program called the Medicare GLP-1 Bridge, running from July 2026 through December 2027, that will cover certain weight loss drugs for eligible beneficiaries. Ozempic is not on the list of covered drugs for this program. The eligible medications are Wegovy (the weight loss version of semaglutide), Zepbound, and Foundayo.
To qualify for the bridge program, Medicare beneficiaries will need a BMI of 35 or higher, or a BMI of 30 or higher with certain conditions like uncontrolled high blood pressure or chronic kidney disease, or a BMI of 27 or higher with conditions like pre-diabetes or a history of heart attack or stroke. A doctor must submit a prior authorization request confirming these criteria.
How U.S. Prices Compare Internationally
The same monthly supply of Ozempic 1 mg costs $936 in the United States. In Canada, it’s $147. In the United Kingdom, $93. In France, $83. The U.S. price is roughly ten times what patients pay in several European countries and Australia. Even Japan, which has the highest price among peer nations, charges just $169 for the same drug.
This price gap is why some people explore purchasing Ozempic from international pharmacies, though doing so comes with risks around product authenticity, proper storage during shipping, and legal gray areas around importing prescription medications.
Compounded Semaglutide as a Lower-Cost Option
Compounding pharmacies have offered custom-made versions of semaglutide (the active ingredient in Ozempic) at significantly lower prices, typically $150 to $250 per month. These are not the same as brand-name Ozempic. They’re mixed by specialty pharmacies and prescribed through telehealth providers or weight loss clinics.
The FDA has raised concerns about the safety and consistency of compounded semaglutide products, and the regulatory landscape around them continues to shift. Some patients have used them successfully as a more affordable alternative, but they lack the standardized manufacturing and testing that FDA-approved medications undergo. If you’re considering this route, verify that the compounding pharmacy is licensed and registered with your state board of pharmacy.
What a Year of Treatment Actually Costs
For a self-pay patient using the manufacturer’s pricing, a realistic first-year cost looks something like this: two months at $199 during the introductory period, then ten months at $349 if you stay at 1 mg or below. That totals roughly $3,888 for the year. If your doctor moves you to the 2 mg dose, those later months jump to $499 each, pushing the annual cost closer to $5,388.
Weight loss with Ozempic isn’t typically a short-term commitment. Most people regain a significant portion of lost weight after stopping the medication, which means you’re looking at ongoing costs for as long as you want to maintain results. Over three to five years, even the discounted self-pay prices add up to $12,000 to $27,000 or more. That long-term financial picture is worth factoring into your decision alongside the monthly number.